By: 19 December 2024
Risk management as an innovation catalyst: Unlocking the potential of ISO 14971 in orthopaedic device development

In the complex field of medical device development, risk management is often perceived as a mountain of paperwork and regulatory hurdles. However, a shift is occurring. ISO 14971, the globally recognised standard for medical device risk management, is evolving into a powerful catalyst for innovation and enhanced patient safety, particularly within the specialised field of orthopaedics. In this article, author Dr Stuart Grant, principle consultant at Archetype Medtech, discusses the potential of ISO 14971 in orthopaedic device development 

 

The unique challenges of orthopaedic devices

Orthopaedics stands apart from other medical device sectors due to its focus on the skeletal system. Unlike soft tissues, bones present unique engineering challenges. The interaction between implants (made of metal or plastic), instruments, and the bone is a critical consideration, as are the associated risks.

Orthopaedic implants, such as hip or knee replacements, are typically designed for longevity, often exceeding 15 years. This extended lifespan within the body presents specific clinical risks. Unlike some surgical devices that can be removed without replacement, orthopaedic implants, once removed, usually necessitate replacement to maintain the structural integrity of the skeletal system. The bone cannot regenerate to fulfil the function of a removed hip or knee joint, for instance. This need for long-term compatibility and durability significantly influences the design and risk assessment of orthopaedic implants.

 

ISO 14971: A catalyst for innovation in orthopaedics

ISO 14971 provides a structured approach to systematically identify, assess, and control risks associated with medical devices. By proactively addressing potential hazards throughout the product lifecycle, companies can not only achieve compliance but also gain a competitive edge. The standard fosters innovation by encouraging a deep understanding of the device’s intended use, its potential interactions with users, patients, and the environment, and the possible harms that could arise.

This knowledge empowers design and engineering teams to develop creative solutions that mitigate risks, enhance safety features, and improve the overall user experience. For instance, in orthopaedics, where the forces exerted on the implant are significant, engineers might innovate materials or surface textures to enhance the bone-implant interface and reduce the risk of loosening or stress shielding.

 

Empowering engineers: Informed decision-making

ISO 14971 equips engineers with a robust framework for making informed design decisions. By clearly defining risk acceptability cri